bioAffinity Technologies, Inc. (BIAF)
NASDAQ: BIAF · Real-Time Price · USD
5.29
+1.88 (55.13%)
At close: Sep 26, 2025, 4:00 PM EDT
4.850
-0.440 (-8.32%)
After-hours: Sep 26, 2025, 7:59 PM EDT
bioAffinity Technologies Market Cap
bioAffinity Technologies has a market cap or net worth of $5.16 million as of September 26, 2025. Its market cap has decreased by -78.49% in one year.
Market Cap
5.16M
Enterprise Value
5.03M
1-Year Change
-78.49%
Ranking
Category
Stock Price
$5.29
Market Cap Chart
Since the IPO on September 1, 2022, bioAffinity Technologies's market cap has decreased from $45.03M to $5.16M, a decrease of -88.53%. That is a compound annual growth rate of -50.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 26, 2025 | 5.16M | -63.59% |
| Dec 31, 2024 | 14.18M | 1.50% |
| Dec 29, 2023 | 13.97M | 4.34% |
| Dec 30, 2022 | 13.39M | -70.26% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 641.51B |
| Johnson & Johnson | 428.03B |
| AbbVie | 386.06B |
| UnitedHealth Group | 312.96B |
| Novo Nordisk | 251.02B |
| Novartis AG | 237.03B |
| Abbott Laboratories | 232.02B |
| AstraZeneca | 226.78B |